These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23829413)

  • 41. [Cysteinyl leukotriene receptor 1 antagonist pranlukast modulates differentiation of SK-N-SH cells].
    Peng F; Fang SH; Zheng XL; Zhang WP; Lu YB; Wei EQ
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2007 Mar; 36(2):123-8. PubMed ID: 17443897
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activation of RARα induces autophagy in SKBR3 breast cancer cells and depletion of key autophagy genes enhances ATRA toxicity.
    Brigger D; Schläfli AM; Garattini E; Tschan MP
    Cell Death Dis; 2015 Aug; 6(8):e1861. PubMed ID: 26313912
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeted gene disruption reveals the role of cysteinyl leukotriene 1 receptor in the enhanced vascular permeability of mice undergoing acute inflammatory responses.
    Maekawa A; Austen KF; Kanaoka Y
    J Biol Chem; 2002 Jun; 277(23):20820-4. PubMed ID: 11932261
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential signaling defects associated with the M201V polymorphism in the cysteinyl leukotriene type 2 receptor.
    Brochu-Bourque A; Véronneau S; Rola-Pleszczynski M; Stankova J
    J Pharmacol Exp Ther; 2011 Feb; 336(2):431-9. PubMed ID: 20966037
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of retinoic acid receptors in the signal pathway of all-trans retinoic acid-induced differentiation in adriamycin-induced podocyte injury.
    Chen XP; Lei FY; Qin YH; Zhou TB; Jiang L; Zhao YJ; Huang WF; Peng QL
    J Recept Signal Transduct Res; 2014 Dec; 34(6):484-92. PubMed ID: 24846581
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Downregulation of angiotensin II type 1 receptor by all-trans retinoic acid in vascular smooth muscle cells.
    Takeda K; Ichiki T; Funakoshi Y; Ito K; Takeshita A
    Hypertension; 2000 Jan; 35(1 Pt 2):297-302. PubMed ID: 10642314
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Leukotriene D4 stimulates the migration but not proliferation of endothelial cells mediated by the cysteinyl leukotriene cyslt(1) receptor via the extracellular signal-regulated kinase pathway.
    Yuan YM; Fang SH; Qian XD; Liu LY; Xu LH; Shi WZ; Zhang LH; Lu YB; Zhang WP; Wei EQ
    J Pharmacol Sci; 2009 Feb; 109(2):285-92. PubMed ID: 19234368
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
    Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E
    Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chemokine stromal cell-derived factor-1 induction by C/EBPbeta activation is associated with all-trans-retinoic acid-induced leukemic cell differentiation.
    Kim KJ; Kim HH; Kim JH; Choi YH; Kim YH; Cheong JH
    J Leukoc Biol; 2007 Nov; 82(5):1332-9. PubMed ID: 17656649
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.
    Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG
    Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271
    [TBL] [Abstract][Full Text] [Related]  

  • 51. All-trans retinoic acid inhibits tumor growth of human osteosarcoma by activating Smad signaling-induced osteogenic differentiation.
    Yang QJ; Zhou LY; Mu YQ; Zhou QX; Luo JY; Cheng L; Deng ZL; He TC; Haydon RC; He BC
    Int J Oncol; 2012 Jul; 41(1):153-60. PubMed ID: 22485251
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Functional expression of cysteinyl leukotriene receptors on human platelets.
    Hasegawa S; Ichiyama T; Hashimoto K; Suzuki Y; Hirano R; Fukano R; Furukawa S
    Platelets; 2010; 21(4):253-9. PubMed ID: 20433311
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Leukotriene D4 induces brain edema and enhances CysLT2 receptor-mediated aquaporin 4 expression.
    Wang ML; Huang XJ; Fang SH; Yuan YM; Zhang WP; Lu YB; Ding Q; Wei EQ
    Biochem Biophys Res Commun; 2006 Nov; 350(2):399-404. PubMed ID: 17010308
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cysteinyl leukotriene receptors.
    Hui Y; Funk CD
    Biochem Pharmacol; 2002 Dec; 64(11):1549-57. PubMed ID: 12429344
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist.
    Nothacker HP; Wang Z; Zhu Y; Reinscheid RK; Lin SH; Civelli O
    Mol Pharmacol; 2000 Dec; 58(6):1601-8. PubMed ID: 11093801
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Additive effects of PI3-kinase and MAPK activities on NB4 cell granulocyte differentiation: potential role of phosphatidylinositol 3-kinase gamma.
    Scholl S; Bondeva T; Liu Y; Clement JH; Höffken K; Wetzker R
    J Cancer Res Clin Oncol; 2008 Aug; 134(8):861-72. PubMed ID: 18288489
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of functional cysteinyl leukotriene receptors by human basophils.
    Gauvreau GM; Plitt JR; Baatjes A; MacGlashan DW
    J Allergy Clin Immunol; 2005 Jul; 116(1):80-7. PubMed ID: 15990778
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Leukotriene D4 induces amyloid-β generation via CysLT(1)R-mediated NF-κB pathways in primary neurons.
    Wang XY; Tang SS; Hu M; Long Y; Li YQ; Liao MX; Ji H; Hong H
    Neurochem Int; 2013 Feb; 62(3):340-7. PubMed ID: 23318673
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The oncogene EVI1 enhances transcriptional and biological responses of human myeloid cells to all-trans retinoic acid.
    Steinmetz B; Hackl H; Slabáková E; Schwarzinger I; Smějová M; Spittler A; Arbesu I; Shehata M; Souček K; Wieser R
    Cell Cycle; 2014; 13(18):2931-43. PubMed ID: 25486480
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inverse agonist activity of selected ligands of the cysteinyl-leukotriene receptor 1.
    Dupré DJ; Le Gouill C; Gingras D; Rola-Pleszczynski M; Stanková J
    J Pharmacol Exp Ther; 2004 Apr; 309(1):102-8. PubMed ID: 14718577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.